Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Neutralizing Activity of BNT162b2-Elicited Serum | Synapse

February 17, 2021New England Journal of Medicine634 citationsOpen Access

View Full Paper

Neutralizing Activity of BNT162b2-Elicited Serum

YLYang LiuQingdao University JLJianying LiuGanzhou People's Hospital HXHongjie XiaBoston University

Key Points

Key points are not available for this paper at this time.

Abstract

Variant SARS-CoV-2 and BNT162b2 Vaccine How well do serum samples obtained from persons injected with the BNT162b2 vaccine neutralize the P.1, B.1.1.7, and B.1.135 lineages of SARS-CoV-2, first ide...

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Liu et al. (Wed,) studied this question.

synapsesocial.com/papers/6a6a905efd493d2318f40c31 https://doi.org/https://doi.org/10.1056/nejmc2102017

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020 · 15,691 citations
2Single-cell landscape of bronchoalveolar immune cells in patients with COVID-192020 · 2,773 citations
3Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates2020 · 2,745 citations
4Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern.2021 · 51 citations
5Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-192020 · 1,382 citations